Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). حسب Ayana Ablayeva (22103708)

الموضوعات:

Upcycling of Postconsumer Recyclate Polypropylene into Low Warping and High Toughness 3D Printable Filaments حسب Animesh Gopal (18521180)

الموضوعات:

The difference of BMD between 2019 and 2022 classify by grop of urinary camium levels measured in 2019. حسب Aroon La-up (14095691)

الموضوعات:

Non-linear relationship between urinary cadmium and bone mineral density from the adjusted restricted cubic splines model. حسب Aroon La-up (14095691)

الموضوعات:

Prevalence of osteoporosis classified by sex, and urinary cadmium level compare between 2019 and 2022. حسب Aroon La-up (14095691)

الموضوعات:

Linear Mixed-Effects Model analysis of bone mineral density changes in relation to urinary cadmium levels in a 3-Year Period. حسب Aroon La-up (14095691)

الموضوعات:

Data. حسب Aroon La-up (14095691)

الموضوعات:

Stratified analysis of the association between urinary cadmium and bone mineral density, by sex. حسب Aroon La-up (14095691)

الموضوعات:

Association between baseline urinary cadmium and the three-year change in bone mineral density (ΔBMD). حسب Aroon La-up (14095691)

الموضوعات:

Characteristics of the study participants for continuous variables. حسب Aroon La-up (14095691)

الموضوعات:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. حسب Claire M. Douglas (21238238)

الموضوعات:

Participant demographic and clinical characteristics. حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... حسب Claire M. Douglas (21238238)

الموضوعات:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... حسب Claire M. Douglas (21238238)

الموضوعات:

S2 Appendix - حسب Shaaista Budhani (21030221)

"…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…"

Outcomes and interventions by group comparison. حسب Shaaista Budhani (21030221)

"…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…"